Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926).
The fibrinolytic characteristics of the endothelial hybrid cell line EA.hy 926, established by fusing a human umbilical vein endothelial cell with a human carcinoma cell line, were studied. The hybrid cell line produced large amounts of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor type 1, and a small amount of urokinase. All plasminogen activator present in conditioned medium was complexed with inhibitor because the cells secreted plasminogen activator inhibitor in excess over plasminogen activator and no activator activity was detectable in conditioned media by direct activity assays. t-PA activator activity was, however, demonstrable in conditioned media after treatment with sodium dodecyl sulfate, in agreement with t-PA antigen determinations. Increased plasminogen activator inhibitor activity could be induced by incubating the cells in the presence of endotoxin or microtubule inhibitors, whereas increased t-PA activity could be induced by microtubule inhibitors. Interleukin-1 had no effect. The fibrinolytic characteristics of the hybrid cell line were stable for at least 30 passages. The perpetual human hybrid cell line EA.hy 926 therefore may be a useful tool for the study of fibrinolysis in cultured endothelial cells.
D002460:Cell Line; D003078:Colchicine / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000502:physiology*; D004731:Endotoxins / Q000494:pharmacology; D005342:Fibrinolysis; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000494:pharmacology; D007700:Kinetics; D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator / Q000378:metabolism*; D014747:Vinblastine / Q000494:pharmacology
D004731:Endotoxins; D006023:Glycoproteins; D007375:Interleukin-1; D015849:Plasminogen Inactivators; D014747:Vinblastine; D010959:Tissue Plasminogen Activator; D003078:Colchicine